Chlamydia Trachomatis - Upgraded Testing Methodology
July 4, 2008: Gamma-Dynacare has upgraded our Chlamydia trachomatis testing methodology to an advanced Gen-Probe Nucleic Acid Transcription Mediated Amplification (TMA) assay with superior sensitivity and specificity.

ColonCancerCheck: Improving Specimen Acceptability
July 4, 2008: Gamma-Dynacare is requesting the assistance of clinicians in helping to improve the rate of Fecal Occult Blood Test (FOBT) specimen acceptability.

Pharmacist Order Forms - ColonCancerCheck FOBT kits
April 1, 2008: Gamma-Dynacare is pleased to participate in the new ColonCancerCheck program launched in Ontario by the Ministry of Health and Long-Term Care and Cancer Care Ontario.

Physician Order Forms - ColonCancerCheck FOBT kits
April 1, 2008: Gamma-Dynacare is pleased to participate in the new ColonCancerCheck program launched by the Ontario Ministry of Health and Long-Term Care and Cancer Care Ontario.

Gamma-Dynacare Expands Its Trace Metals Testing
December 1, 2007: Gamma-Dynacare Medical Laboratories has recently expanded its trace metal testing platform utilizing the latest technology used for trace metal detection, identification and quantification.

Gamma-Dynacare Offers the Only FDA-Approved HPV Screening Test
December 1, 2007: Gamma-Dynacare Medical Laboratories offers an advanced technology and the ONLY FDA-approved adjunctive screening test available.